Literature DB >> 33936727

Long-standing hypercalcemia in a 78-years old woman.

Andreas Kiriakopoulos1, Dimitrios Linos2.   

Abstract

A 78 years-old woman was found with worsening hypercalcemia, osteopenia and memory loss during the past 2 years. Multiple, repeated imaging studies failed to reveal the etiology of the primary hyperparathyroidism. Bilateral neck exploration revealed a 4.5 × 2.3 cm right superior parathyroid adenoma in an ectopic position.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  neck U/S; neck exploration; parathyroid adenoma; parathyroidectomy; primary hyperparathyroidism; sesta‐MIBI scanning

Year:  2021        PMID: 33936727      PMCID: PMC8077251          DOI: 10.1002/ccr3.3994

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN: 2050-0904


CASE PRESENTATION

A 78‐year‐old woman was referred due to worsening hypercalcemia during the past 2 years. She complained of memory loss and was found with osteopenia (hip T‐score: −2.3 on DXA scan). Her past medical and family history was unremarkable. Calcium and PTH serum levels were 11.6 mg/dL and 156 pg/mL 2 years prior and 13.6 mg/dL and 662 pg/mL on admission (normal values: 8.4‐10.1 and 15‐65, respectively). Albumin, vitamin D, and kidney function were normal. Neck ultrasound/CT/MRI and sesta‐MIBI did not found any pathologic findings (Figure 1A,B).
FIGURE 1

A, Neck CT scanning with IV contrast and transverse neck U/S showing no pathologic findings from the parathyroid glands. B, Sesta‐MIBI scanning 10 min and 120 min after the injection of the radiotracer without pathologic focal uptake

A, Neck CT scanning with IV contrast and transverse neck U/S showing no pathologic findings from the parathyroid glands. B, Sesta‐MIBI scanning 10 min and 120 min after the injection of the radiotracer without pathologic focal uptake

Q: What is the diagnosis?

Bilateral 4‐gland exploration revealed a right superior parathyroid adenoma at the lower paratracheal area (Figure 2). Histology confirmed the presence of an encapsulated, 10 gr/4.5 × 2.3 cm, parathyroid adenoma. A peripheral rim of normal glandular tissue was identified.
FIGURE 2

Large right superior parathyroid adenoma found at the lower right paratracheal area

Large right superior parathyroid adenoma found at the lower right paratracheal area Primary hyperparathyroidism is the most common cause of hypercalcemia in the adult population. The diagnosis is biochemical and entails an inappropriately high PTH level despite high‐normal/high Ca++ serum level. Secondary causes of PTH elevation should be ruled out. Imaging studies do not aid in the diagnosis and are not used for selecting patients for surgical referral. Even though various minimally invasive techniques do exist, open bilateral 4‐gland exploration is the preferred operative strategy in cases with discordant or negative preoperative localization studies. ,

CONFLICT OF INTEREST

None to declare.

AUTHOR CONTRIBUTIONS

AK: designed and implemented the study, or wrote the manuscript. DL: designed or critically reviewed the manuscript.

ETHICAL APPROVAL

There are no identification details of the patient in the studies provided, and an informed consent was taken.

INFORMED CONSENT

Informed consent was obtained from the patient in order to use the imaging studies.
  2 in total

1.  The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.

Authors:  Scott M Wilhelm; Tracy S Wang; Daniel T Ruan; James A Lee; Sylvia L Asa; Quan-Yang Duh; Gerard M Doherty; Miguel F Herrera; Janice L Pasieka; Nancy D Perrier; Shonni J Silverberg; Carmen C Solórzano; Cord Sturgeon; Mitchell E Tublin; Robert Udelsman; Sally E Carty
Journal:  JAMA Surg       Date:  2016-10-01       Impact factor: 14.766

2.  Bilateral neck exploration decreases operative time compared to minimally invasive parathyroidectomy in patients with discordant imaging.

Authors:  Matthew A Nehs; Daniel T Ruan; Atul A Gawande; Francis D Moore; Nancy L Cho
Journal:  World J Surg       Date:  2013-07       Impact factor: 3.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.